PCM
ABBV icon

Peirce Capital Management’s AbbVie ABBV Stock Holding History

Peirce Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$220K Buy
+873
New +$188K 0.08% 44
2025
Q4 		– Sell
-873
Closed -$202K – 44
2025
Q3 		$202K Buy
+873
New +$178K 0.08% 40

Other funds holding ABBV

Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Peirce Capital Management's ABBV Position: Q2 2026 in Review

Peirce Capital Management opened a new position in AbbVie (ABBV) in Q2 2026: 873 shares worth $220K. The stake represents 0.08% of the portfolio and ranks #44 among its holdings. This is a return to the name: Peirce Capital Management previously reported a position in ABBV as recently as Q3 2025.

Peirce Capital Management first reported a position in ABBV in Q3 2025 and has held it in 2 quarters since. 2,236 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Peirce Capital Management held 873 shares of AbbVie worth $220K as of Q2 2026.
  • AbbVie was a new Peirce Capital Management position in Q2 2026.
  • AbbVie made up 0.08% of Peirce Capital Management's portfolio in Q2 2026, its #44 holding.
  • Peirce Capital Management first reported a position in AbbVie in Q3 2025 and has held it in 2 quarters since.
  • 2,236 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Peirce Capital Management's 13F filing for Q2 2026, filed 10 Jul 2026.